Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Patricia Vella Bonanno, Anna Bucsics, Steven Simoens, Antony P Martin, Wija Oortwijn, Jolanta Gulbinovič, Celia Rothe, Angela Timoney, Alessandra Ferrario, Mohamed Gad, Ahmed Salem, Iris Hoxha, Robert Sauermann, Maria Kamusheva, Maria Dimitrova, Guenka Petrova, Ott Laius, Gisbert Selke, Vasilios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Arianit Jakupi, Tomasz Bochenek, Magdalene Wladysiuk, Claudia Furtado, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Jurij Fürst, Dominik Tomek, Merce Obach Cortadellas, Corrine Zara, Alan Haycox, Stephen Campbell & Brian Godman. (2019) Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA. Expert Review of Pharmacoeconomics & Outcomes Research 19:3, pages 251-261.
Read now
Read now
Nika Mardetko, Mitja Kos & Sabine Vogler. (2019) Review of studies reporting actual prices for medicines. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 159-179.
Read now
Read now
Jörg Mahlich, Jörn Sindern & Moritz Suppliet. (2019) Cross-national drug price comparisons with economic weights in external reference pricing in Germany. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 37-43.
Read now
Read now
Articles from other publishers (14)
Aniek Dane, Anne-Sophie Klein Gebbink, Jan-Dietert Brugma, Albane Degrassat-Théas, Martin J. Hug, Morten B. Houlind, P. Paubel, P. Hugo M. van der Kuy & Carin A. Uyl-de Groot. (2023) Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices. Applied Health Economics and Health Policy 21:6, pages 905-914.
Crossref
Crossref
Arif Ibne Asad & Boris Popesko. (2022) Contemporary challenges in the European pharmaceutical industry: a systematic literature review. Measuring Business Excellence 27:2, pages 277-290.
Crossref
Crossref
Sabine Vogler. (2022) Prices of new medicines: International analysis and policy options. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 175, pages 96-102.
Crossref
Crossref
Jules M Janssen Daalen, Anouk den Ambtman, Mark Van Houdenhoven & Bart J F van den Bemt. (2021) Determinants of drug prices: a systematic review of comparison studies. BMJ Open 11:7, pages e046917.
Crossref
Crossref
Kah Seng Lee, Yaman Walid Kassab, Nur Akmar Taha & Zainol Akbar Zainal. (2021) A systematic review of pharmaceutical price mark-up practice and its implementation. Exploratory Research in Clinical and Social Pharmacy 2, pages 100020.
Crossref
Crossref
VÉRONIQUE C. RAIMOND, WILLIAM B. FELDMAN, BENJAMIN N. ROME & AARON S. KESSELHEIM. (2021) Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. The Milbank Quarterly 99:1, pages 240-272.
Crossref
Crossref
Sabine Vogler. 2021. Arzneimittel-Kompass 2021. Arzneimittel-Kompass 2021
125
138
.
Zornitsa Mitkova, Mariya Vasileva, Alexandra Savova, Manoela Manova, Silvia Terezova & Guenka Petrova. (2020) Comparison of Cardiovascular Medicines Prices in Four European Countries. Frontiers in Public Health 8.
Crossref
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Crossref
Wim H. van Harten, Riin Ots & Valesca P. Retèl. (2019) The tip of the iceberg? Budget restrictions and patient perspectives on cancer drug costs: An international survey in 29 hospitals and 56 patient organizations. Journal of Cancer Policy 21, pages 100195.
Crossref
Crossref
Sabine Vogler, Peter Schneider & Nina Zimmermann. (2019) Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. PharmacoEconomics - Open 3:3, pages 303-309.
Crossref
Crossref
M.T. Svendsen, M.S. Ernst, K.E. Andersen, F. Andersen, H. Johannessen & A. Pottegård. (2018) Use of topical antipsoriatic drugs in Denmark: a nationwide drug utilization study. British Journal of Dermatology 180:1, pages 157-164.
Crossref
Crossref
Sabine Vogler. 2018. Equitable Access to High-Cost Pharmaceuticals. Equitable Access to High-Cost Pharmaceuticals
143
164
.
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl & Alan Haycox. (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. Frontiers in Pharmacology 8.
Crossref
Crossref